Advertisement
Home Tags Cancer: Breast

Tag: Cancer: Breast

Single-agent talazoparib provides significant benefit over standard chemotherapy for patients with advanced breast cancer and germline BRCA1/2 mutation

Talazoparib Beneficial in Patients With Advanced Breast Cancer

0
Longer progression-free survival versus standard chemotherapy for patients with germline BRCA1/2
The combination of digital mammography and digital breast tomosynthesis detects 90 percent more breast cancers than digital mammography alone

Combined Digital Screening Best for Detecting Breast Cancers

0
Digital mammography and tomosynthesis better than digital mammography alone
The American Society for Clinical Oncology has endorsed the Society for Integrative Oncology guideline on the use of integrative therapies during and after breast cancer treatment

ASCO Endorses SIO Guideline for Integrative Tx in Breast Cancer

0
Guideline recommends therapies for reducing anxiety/stress, depression/mood disorders, nausea
The C-509T allele in the promoter region of transforming growth factor β is associated with radiation-induced breast fibrosis risk among patients with early-stage breast cancer

TGFB1 Mutation Ups Radiation-Induced Breast Fibrosis Risk

0
C-509T allele and postoperative cosmetic surgery significantly linked to breast fibrosis risk
Acupuncture may cut joint pain among postmenopausal women with early-stage breast cancer and aromatase inhibitor-related pain

Acupuncture May Cut Arthralgia From Aromatase Inhibitors

0
Clinical significance of the pain reduction remains uncertain
A magnetic system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy has been approved by the U.S. Food and Drug Administration.

FDA Approves Magnetic System for Guiding Lymph Node Biopsies

0
Sentimag System uses magnetic detection to identify sentinel lymph nodes for surgical removal
The U.S. Food and Drug Administration has approved ribociclib in combination with an aromatase inhibitor as an initial endocrine-based therapy for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor-positive

FDA Grants First Approval for CA Drug Under New Pilot Programs

0
Ribociclib approved in combo with AI as endocrine tx for HR-positive, HER2-negative advanced breast CA
Higher levels of vitamin D may be protective against breast cancer

Higher Vitamin D Levels May Lower Breast Cancer Risk

0
Pooled analysis finds levels ≥60 ng/mL are most protective among women aged 55 years and older
The attending surgeon is associated with variation in the receipt of genetic testing after breast cancer diagnosis

Attending Surgeon Influences Genetic Testing in Breast Cancer

0
About one-third of surgeon variation explained by patient volume, surgeon attitudes to genetic testing
Risk-stratified breast screening improves the cost-effectiveness of screening

Risk-Stratified Breast Cancer Screening Ups Cost-Effectiveness

0
Risk-stratified screening can reduce overdiagnosis and maintain benefits of screening